Treatment results of 84 patients with nasopharyngeal carcinoma in childhood
- 30 September 2005
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 46 (4) , 454-458
Abstract
Background: To evaluate the clinical characteristics, treatment regimens, survival, and late complications in patients with nasopharyngeal carcinoma.Procedure: Eighty‐four patients diagnosed with nasopharyngeal carcinoma between 1972 and 2002 were retrospectively evaluated. Tumor status, lymph node involvement, metastasis, and stage were assessed according to the TNM classification. All patients were treated with radiotherapy and chemotherapy. Chemotherapeutic regimens involved cyclophosphamide from 1972 to 1982, vincristine + cyclophosphamide + epirubicine and actinomycin‐D protocol from 1982 to 1999 and cisplatin + methotrexate + 5‐fluorouracil with leucovorine rescue after 1999. Mean and median values were used for the demographic characteristics. Kaplan–Meier survival curves were used for survival analysis. The patient groups were compared in terms of survival duration using a log‐rank test.Results: There were 51 males and 33 females with a median age of 13 years (7–17) at diagnosis. At the time of diagnosis, 78.5% of the patients were at advanced stage (stages III and IV). Overall and event‐free survival rates were 56.3% and 50.1%, respectively. Survival was inversely affected by advanced nodal status (P = 0.01). The survival rates (80%) were found higher with cisplatin + methotrexate + 5‐fluorouracil + leucovorine rescue regimen. The most frequent late complications after therapy were hypothyroidism (9.5%), dental caries (7.1%), and trismus (7.1%).Conclusion: The cisplatin‐based regimen was the best chemotherapeutic regimen. Less toxic regimens with better survival rates should be investigated in patients with nasopharyngeal carcinoma. Pediatr Blood Cancer 2006, 46:454–458.Keywords
This publication has 32 references indexed in Scilit:
- Preradiation chemotherapy with methotrexate, cisplatin, 5‐fluorouracil, and leucovorin for pediatric nasopharyngeal carcinomaCancer, 2005
- Second neoplasms after treatment of childhood cancer in SloveniaPediatric Blood & Cancer, 2004
- Nasopharyngeal carcinoma in childhood and adolescenceEuropean Journal of Cancer, 2003
- NASOPHARYNGEAL CARCINOMA IN TURKISH CHILDREN: Review of 33 CasesPediatric Hematology and Oncology, 2001
- Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heatInternational Journal of Epidemiology, 2000
- Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Nasopharyngeal carcinoma in children: Retrospective review of 50 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survivalInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Treatment and outcome of undifferentiated carcinoma of the nasopharynx in childhood: A 13‐year experienceMedical and Pediatric Oncology, 1986
- Studies on nasopharyngeal carcinoma in the sudan—I. Epidemiology and aetiologyEuropean Journal of Cancer and Clinical Oncology, 1983